414 related articles for article (PubMed ID: 23627585)
1. Deep dermal fibroblast profibrotic characteristics are enhanced by bone marrow-derived mesenchymal stem cells.
Ding J; Ma Z; Shankowsky HA; Medina A; Tredget EE
Wound Repair Regen; 2013; 21(3):448-55. PubMed ID: 23627585
[TBL] [Abstract][Full Text] [Related]
2. Bone marrow derived mesenchymal stem cells inhibit the proliferative and profibrotic phenotype of hypertrophic scar fibroblasts and keloid fibroblasts through paracrine signaling.
Fang F; Huang RL; Zheng Y; Liu M; Huo R
J Dermatol Sci; 2016 Aug; 83(2):95-105. PubMed ID: 27211019
[TBL] [Abstract][Full Text] [Related]
3. Fibrotic remodeling of tissue-engineered skin with deep dermal fibroblasts is reduced by keratinocytes.
Varkey M; Ding J; Tredget EE
Tissue Eng Part A; 2014 Feb; 20(3-4):716-27. PubMed ID: 24090416
[TBL] [Abstract][Full Text] [Related]
4. Differential collagen-glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: potential therapeutic targets for hypertrophic scar.
Varkey M; Ding J; Tredget EE
Biomaterials; 2011 Oct; 32(30):7581-91. PubMed ID: 21802722
[TBL] [Abstract][Full Text] [Related]
5. Novel methods for the investigation of human hypertrophic scarring and other dermal fibrosis.
Honardoust D; Kwan P; Momtazi M; Ding J; Tredget EE
Methods Mol Biol; 2013; 1037():203-31. PubMed ID: 24029937
[TBL] [Abstract][Full Text] [Related]
6. Increased TGF-beta-producing CD4+ T lymphocytes in postburn patients and their potential interaction with dermal fibroblasts in hypertrophic scarring.
Wang J; Jiao H; Stewart TL; Shankowsky HA; Scott PG; Tredget EE
Wound Repair Regen; 2007; 15(4):530-9. PubMed ID: 17650097
[TBL] [Abstract][Full Text] [Related]
7. Dermis, acellular dermal matrix, and fibroblasts from different layers of pig skin exhibit different profibrotic characteristics: evidence from in vivo study.
Zuo Y; Lu S
Oncotarget; 2017 Apr; 8(14):23613-23627. PubMed ID: 28423561
[TBL] [Abstract][Full Text] [Related]
8. Features of wound healing shown by fibroblasts obtained from the superficial and deep dermis.
Kaminishi-Tanikawa A; Kurita M; Okazaki M; Kawaguchi R; Ihara A; Niikura M; Takushima A; Harii K
J Plast Surg Hand Surg; 2011 Sep; 45(4-5):219-25. PubMed ID: 22150144
[TBL] [Abstract][Full Text] [Related]
9. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring.
Crawford J; Nygard K; Gan BS; O'Gorman DB
Exp Dermatol; 2015 Feb; 24(2):120-6. PubMed ID: 25421393
[TBL] [Abstract][Full Text] [Related]
10. Differential expression of IGFBPs by normal and hypertrophic scar fibroblasts.
Hathaway CL; Arnold AM; Rand RP; Engrav LH; Quinn LS
J Surg Res; 1996 Jan; 60(1):156-62. PubMed ID: 8592408
[TBL] [Abstract][Full Text] [Related]
11. Stromal cell-derived factor 1 (SDF-1) and its receptor CXCR4 in the formation of postburn hypertrophic scar (HTS).
Ding J; Hori K; Zhang R; Marcoux Y; Honardoust D; Shankowsky HA; Tredget EE
Wound Repair Regen; 2011; 19(5):568-78. PubMed ID: 22092795
[TBL] [Abstract][Full Text] [Related]
12. Dermal fibroblasts from different layers of human skin are heterogeneous in expression of collagenase and types I and III procollagen mRNA.
Ali-Bahar M; Bauer B; Tredget EE; Ghahary A
Wound Repair Regen; 2004; 12(2):175-82. PubMed ID: 15086769
[TBL] [Abstract][Full Text] [Related]
13. Imbalance between activin A and follistatin drives postburn hypertrophic scar formation in human skin.
Fumagalli M; Musso T; Vermi W; Scutera S; Daniele R; Alotto D; Cambieri I; Ostorero A; Gentili F; Caposio P; Zucca M; Sozzani S; Stella M; Castagnoli C
Exp Dermatol; 2007 Jul; 16(7):600-10. PubMed ID: 17576240
[TBL] [Abstract][Full Text] [Related]
14. Lapachol suppresses cell proliferation and secretion of interleukin-6 and plasminogen activator inhibitor-1 of fibroblasts derived from hypertrophic scars.
Matsui T; Ito C; Oda M; Itoigawa M; Yokoo K; Okada T; Furukawa H
J Pharm Pharmacol; 2011 Jul; 63(7):960-6. PubMed ID: 21635262
[TBL] [Abstract][Full Text] [Related]
15. Effect of heparin on production of transforming growth factor (TGF)-beta1 and TGF-beta1 mRNA expression by human normal skin and hyperplastic scar fibroblasts.
Fan SQ; Cai JL; Qin LY; Wang ZH; Liu ZZ; Sun ML
Ann Plast Surg; 2008 Mar; 60(3):299-305. PubMed ID: 18443513
[TBL] [Abstract][Full Text] [Related]
16. The use of laser Doppler imaging as a predictor of burn depth and hypertrophic scar postburn injury.
Stewart TL; Ball B; Schembri PJ; Hori K; Ding J; Shankowsky HA; Tredget EE;
J Burn Care Res; 2012; 33(6):764-71. PubMed ID: 22955162
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis.
Wu Y; Chen L; Scott PG; Tredget EE
Stem Cells; 2007 Oct; 25(10):2648-59. PubMed ID: 17615264
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells suppress fibroblast proliferation and reduce skin fibrosis through a TGF-β3-dependent activation.
Wu Y; Peng Y; Gao D; Feng C; Yuan X; Li H; Wang Y; Yang L; Huang S; Fu X
Int J Low Extrem Wounds; 2015 Mar; 14(1):50-62. PubMed ID: 25858630
[TBL] [Abstract][Full Text] [Related]
19. The therapeutic potential of a C-X-C chemokine receptor type 4 (CXCR-4) antagonist on hypertrophic scarring in vivo.
Ding J; Ma Z; Liu H; Kwan P; Iwashina T; Shankowsky HA; Wong D; Tredget EE
Wound Repair Regen; 2014; 22(5):622-30. PubMed ID: 25139227
[TBL] [Abstract][Full Text] [Related]
20. Direct comparison of the potency of human mesenchymal stem cells derived from amnion tissue, bone marrow and adipose tissue at inducing dermal fibroblast responses to cutaneous wounds.
Liu X; Wang Z; Wang R; Zhao F; Shi P; Jiang Y; Pang X
Int J Mol Med; 2013 Feb; 31(2):407-15. PubMed ID: 23228965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
